-
EP2505586
European procedure
Extract from the Register of European Patents
EP About this file: EP2505586
| EP2505586 - INDOLE COMPOUND AND PHARMACEUTICAL USE THEREOF [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 06.01.2017 Database last updated on 29.10.2024 | Most recent event Tooltip | 06.01.2017 | No opposition filed within time limit | published on 08.02.2017 [2017/06] | Applicant(s) | For all designated states Japan Tobacco, Inc. 2-1, Toranomon 2-chome Minato-ku Tokyo 105-8422 / JP | [N/P] |
| Former [2012/40] | For all designated states Japan Tobacco, Inc. 2-1, Toranomon 2-chome Minato-ku Tokyo 105-8422 / JP | Inventor(s) | 01 /
INOUE, Teruhiko c/o Central Pharmaceutical Research Institute of Japan Tobacco Inc. 1-1, Murasaki-cho Takatsuki-shi Osaka 569-1125 / JP | 02 /
KAYA, Tetsudo c/o Central Pharmaceutical Research Institute of Japan Tobacco Inc. 1-1, Murasaki-cho Takatsuki-shi Osaka 569-1125 / JP | 03 /
KIKUCHI, Shinichi c/o Central Pharmaceutical Research Institute of Japan Tobacco Inc. 1-1, Murasaki-cho Takatsuki-shi Osaka 569-1125 / JP | 04 /
MATSUMURA, Koji c/o Central Pharmaceutical Research Institute of Japan Tobacco Inc. 1-1, Murasaki-cho Takatsuki-shi Osaka 569-1125 / JP | 05 /
MASUO, Ritsuki c/o Central Pharmaceutical Research Institute of Japan Tobacco Inc. 1-1, Murasaki-cho Takatsuki-shi Osaka 569-1125 / JP | 06 /
SUZUKI, Motoya c/o Central Pharmaceutical Research Institute of Japan Tobacco Inc. 1-1, Murasaki-cho Takatsuki-shi Osaka 569-1125 / JP | 07 /
MAEKAWA, Michihide c/o Central Pharmaceutical Research Institute of Japan Tobacco Inc. 1-1, Murasaki-cho Takatsuki-shi Osaka 569-1125 / JP | [2012/40] | Representative(s) | Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstrasse 3 81675 München / DE | [2016/09] |
| Former [2012/40] | Harmsen, Dirk Vossius & Partner Siebertstrasse 4 81675 München / DE | Application number, filing date | 10833248.7 | 25.11.2010 | [2016/09] | WO2010JP70988 | Priority number, date | JP20090268040 | 25.11.2009 Original published format: JP 2009268040 | [2012/40] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2011065402 | Date: | 03.06.2011 | Language: | JA | [2011/22] | Type: | A1 Application with search report | No.: | EP2505586 | Date: | 03.10.2012 | Language: | EN | [2012/40] | Type: | B1 Patent specification | No.: | EP2505586 | Date: | 02.03.2016 | Language: | EN | [2016/09] | Search report(s) | International search report - published on: | JP | 03.06.2011 | (Supplementary) European search report - dispatched on: | EP | 17.04.2013 | Classification | IPC: | C07D401/14, A61K31/416, A61K31/4178, A61K31/422, A61K31/427, A61K31/433, A61K31/437, A61K31/4439, A61K31/454, A61K31/496, A61K31/5377, A61K31/55, A61P29/00, A61P37/02, A61P37/06, A61P37/08, A61P43/00, C07D403/04, C07D403/14, C07D405/14 | [2012/40] | CPC: |
C07D403/04 (EP,KR,US);
A61K31/404 (KR);
A61K31/416 (KR);
A61K31/5377 (KR);
C07D401/14 (KR,US);
C07D403/14 (KR,US);
C07D405/14 (KR,US);
C07D413/14 (KR,US);
C07D417/14 (KR,US);
C07D471/04 (KR,US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2012/40] | Extension states | BA | 15.06.2012 | ME | 15.06.2012 | Title | German: | INDOLVERBINDUNG UND IHRE PHARMAZEUTISCHE VERWENDUNG | [2012/40] | English: | INDOLE COMPOUND AND PHARMACEUTICAL USE THEREOF | [2012/40] | French: | COMPOSÉ D'INDOLE ET UTILISATION PHARMACEUTIQUE DE CELUI-CI | [2012/40] | Entry into regional phase | 15.06.2012 | Translation filed | 15.06.2012 | National basic fee paid | 15.06.2012 | Search fee paid | 15.06.2012 | Designation fee(s) paid | 15.06.2012 | Examination fee paid | Examination procedure | 15.06.2012 | Examination requested [2012/40] | 12.11.2013 | Amendment by applicant (claims and/or description) | 17.03.2014 | Despatch of a communication from the examining division (Time limit: M02) | 26.05.2014 | Reply to a communication from the examining division | 15.07.2014 | Communication of intention to grant the patent | 25.11.2014 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 20.01.2015 | Communication of intention to grant the patent | 28.05.2015 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 22.06.2015 | Communication of intention to grant the patent | 09.12.2015 | Fee for grant paid | 09.12.2015 | Fee for publishing/printing paid | 17.12.2015 | Information about intention to grant a patent | 17.12.2015 | Receipt of the translation of the claim(s) | Divisional application(s) | EP16158053.5 / EP3059234 | EP20189306.2 / EP3766877 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 17.03.2014 | Opposition(s) | 05.12.2016 | No opposition filed within time limit [2017/06] | Fees paid | Renewal fee | 23.11.2012 | Renewal fee patent year 03 | 25.11.2013 | Renewal fee patent year 04 | 24.11.2014 | Renewal fee patent year 05 | 25.11.2015 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]US2007254937 (JURCAK JOHN G [US], et al) [A] 1-26 * claims 1, 17 *; | [A]US2007293499 (FLYNN GARY A [US], et al) [A] 1-26* claims 6-23 * | International search | [Y]JP2003231687 (JAPAN TOBACCO INC); | [A]WO2007076228 (BOEHRINGER INGELHEIM INT [DE], et al); | [A]WO2007088401 (MERCK SHARP & DOHME [GB], et al); | [Y]WO2008135785 (ASTRAZENECA AB [SE], et al) |